Eastern Regional Health Authority

St. John's, Newfoundland and Labrador A1B3V6

0 studies enrolling now · 6 studies all time

What they study most

Antimicrobial, Bacteremia, Critically Ill, Diffuse Large B-cell Lymphoma, Follicular Lymphoma (FL), Intensive Care, Marginal Zone Lymphoma, Mortality, Non Hodgkin Lymphoma, Post-essential Thrombocythemia Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Primary Myelofibrosis

Studies at this site

• Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL — Running, not enrolling
• A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis — Running, not enrolling
• Phase 3 Study of Zandelisib (ME-401) in Combination With Rituximab in Patients With iNHL - (COASTAL) — Stopped early
• Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness — Completed
• Correlation Between Coronary and Carotid Atherosclerotic Disease and Links With Clinical Outcomes — Completed
• Surveillance of Safety and Efficacy of Wilate in Patients With Von Willebrand Disease — Completed